FLHLF (Filament Health) EBIT per Share : $-0.01 (TTM As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Filament Health EBIT per Share?

Filament Health's EBIT per Share for the three months ended in Dec. 2024 was $-0.01. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2024 was $-0.01.

During the past 3 years, the average EBIT per Share Growth Rate was 32.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Filament Health's EBIT per Share or its related term are showing as below:

FLHLF' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 32.6 Med: 32.6 Max: 32.6
Current: 32.6

During the past 5 years, the highest 3-Year average EBIT per Share Growth Rate of Filament Health was 32.60% per year. The lowest was 32.60% per year. And the median was 32.60% per year.

FLHLF's 3-Year EBIT Growth Rate is ranked better than
78.1% of 822 companies
in the Drug Manufacturers industry
Industry Median: 8.15 vs FLHLF: 32.60

Filament Health's EBIT for the three months ended in Dec. 2024 was $-1.44 Mil.

Filament Health EBIT per Share Historical Data

The historical data trend for Filament Health's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Filament Health EBIT per Share Chart

Filament Health Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

EBIT per Share

-0.05

-0.07

-0.02

-0.01

Filament Health Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
EBIT per Share	Get a 7-Day Free Trial												-	-	-	-	-0.01

Filament Health EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Filament Health's EBIT per Share for the fiscal year that ended in Dec. 2024 is calculated as

	EBIT per Share		(A: Dec. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-3.321	/	237.383
=	-0.01

Filament Health's EBIT per Share for the quarter that ended in Dec. 2024 is calculated as

	EBIT per Share		(Q: Dec. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-1.437	/	261.727
=	-0.01

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.01

Filament Health (OTCPK:FLHLF) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Filament Health EBIT per Share Related Terms

Thank you for viewing the detailed overview of Filament Health's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Filament Health Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Filament Health Corp (OTCPK:FLHLF) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

7QS:Germany FH:Canada

Address

4475 Wayburne Drive, Unit 210, Burnaby, BC, CAN, V5G 4X4

Website

https://www.filament.health

Filament Health Corp is a natural psychedelic drug development company. Its mission is to see safe, approved, natural psychedelics in the hands of everyone who needs them as soon as possible. The group engages in natural extraction technology commercialization, utilizing its intellectual property portfolio, in-house GMP facility, and Health Canada psilocybin Dealer's License.

Filament Health Headlines

From GuruFocus

Filament Health Corp at OTC Markets KCSA Mental Health Investor Conference Transcript

By GuruFocus Research • 02-13-2024

Filament Health to Webcast Live at VirtualInvestorConferences.com October 14th

By PRNewswire PRNewswire • 10-13-2021

Filament Health to Webcast Live at VirtualInvestorConferences.com April 28th

By GuruFocusNews GuruFocusNews • 04-25-2022